Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation
https://doi.org/10.22416/1382-4376-2017-27-5-57-64
Abstract
Aim of investigation. To study the urinary infection rate in patients with liver cirrhosis (LC) and indications for liver transplantation with assessment of etiologic spectrum and features of the progression of liver disease at development of this complication. Material and methods. The study included patients with liver cirrhosis Child Pugh class B and C with indications for liver transplantation, who were hospitalized at Sverdlovsk Regional hepatological center for liver disease decompensation in 2015 (n=137). Results. Of all enrolled patients 28,5% had urinary infectious complications. In those with more severe liver decompensation (Child-Pugh class C), the rate of patients with urinary tract infection was higher (66,7%). The most commen signs included leukocyturia and bacteriuria. Esсheriсhia сoli и Klebsiella pneumoniae were the most common infectious agents in liver cirrhosis patients. Frequency of urinary tract infections was higher in those with severe liver cirrhosis complications (in past history as well) such as hepatic encephalopathy, ascites, spontaneous bacterial peritonitis. Conclusion. High frequency of infections at decompensated liver cirrhosis require thorough examination of these patients using all available diagnostic methods. Early diagnostics and treatment of urinary tract infections is of paramount importance for patients, listed for liver transplantation, for it can help to keep the patient in waiting list and improve the operation outcomes.
About the Authors
P. D. Bessonov
State government-financed healthcare institution «Sverdlovsk Regional Hospital №1»
Russian Federation
Russian Federation
I. V. Borzunov
State educational government-financed institution of higher professional education «Ural State Medical University»
Russian Federation
Russian Federation
E. N. Bessonova
State government-financed healthcare institution «Sverdlovsk Regional Hospital №1»
Russian Federation
Russian Federation
References
1. Буеверов А.О., Маевская М.В. Особенности лечения и подходы в терапии различных вариантов печеноч- ной энцефалопатии. Трудный пациент 2006; 10:9-13.
2. Бессонова Е.Н. Изменение этиологической структу- ры ЦП с 2005 по 2010 год в Свердловской обла- сти. Медицинский вестник Северного Кавказа 2012; 2(26):52-4.
3. Еремеева Л.Ф., Ямпольский А.Ф. Экстракорпоральные методы лечения у пациентов с печеночно-клеточной недостаточностью. Актуальные проблемы транспорт- ной медицины 2010; 4(22):139-49.
4. Полевщиков Е.Е., Рябинин В.Е., Турин А.Я., Долматов И.И. Альбуминовый диализ: терапия острой почечной недостаточности. Рос журн гастроэнтерол гепатол колопроктол 2007; 1:5-6
5. Amato А., Precone D.F., Carannante N. Prevalence and risk factors for bacteriuria in patients with cirrhosis. Le Infezioni in Medicina 2005; 2:103-8.
6. Cruz R. Urinary tract infection in non-hospitalized patients with cirrhosis and no symptoms of urinary tract infection: a case series study. Brazil J Infect Dis 2006; 10: 380-3.
7. Wiesner R., Edwards E., Freeman R. Model for end stage liver disease (МELD) and al location of donor livers. Gastroenterology 2003; 124: 91-101.
8. Cruz R. Urinary tract infection in non-hospitalized patients with cirrhosis and no symptoms of urinary tract infection: a case series study. Brazil J Infect Dis 2006;10:380-3.
9. Killenberg P.G., Clavien P.A. Medical Care of the Liver Transplant Patient. 3rd Ed. Blackwell Publishing; 2006. P. 47-58.
10. Малаева Е.Г. Инфекции мочевой системы у пациентов с циррозом печени. Проблемы здоровья и экологии 2012;1.
11. Biggins S.W., Kim W.R., Terrault N.A. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130:1652-60.
12. Goralczyk A.D., Abu-Ajaj W., Tsui T.Y. Liver transplantation in patients with liver cirrhosis and active pneumonia: an observational study. Transpl International 2011; 24(11):1068-74.
13. Moller S., Henriksen J.H. Cardiovascular complications of cirrhosis. Gut 2008; 57:268-78.
14. Grabe M., Bjerklund-Johansen T.E., Botto H., Çek M, Naber K.G., Tenke P., Wagenlehner F. Guidelines on urological infections. Text update 2010. April 147-50.
15. Garcia-Tsao G., Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Practice and Research. Clin Gastroenterol 2004; 18(2):353-72.
16. Bajaj J.S., O’Leary J.B., Reddy R.K., Wong F., Olson J.C., Subramanian R.M., Brown G., Noble N.A., Thacker L.R., Kamath P.S. Second infections indepen- dently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end stage liver disease (NACSELD) experience. Hepatology 2012; 56:2328-35.
17. Wasmuth H.E., Kunz D., Yagmur E. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol 2005; 42(2):195-201.
18. Christou L., Pappas G., Falagas M. Bacterial infection related morbidity and mortality in cirrhosis. Am J Gastroenterol 2007; 102:1510-7.
19. Жаркова М.С., Маевская М.В., Ивашкин В.Т. Современный взгляд на бактериальные осложнения при циррозе печени. Рос журн гастроэнтерол гепа- тол колопроктол 2010; 20(6):61-9.1. Буеверов А.О., Маевская М.В. Особенности лечения и подходы в терапии различных вариантов печеноч- ной энцефалопатии. Трудный пациент 2006; 10:9-13.
Review
For citations:
Bessonov P.D., Borzunov I.V., Bessonova E.N. Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(5):57-64. (In Russ.) https://doi.org/10.22416/1382-4376-2017-27-5-57-64
Views:
827
Email this article 
